Corporate Banner
Satellite Banner
Biomolecular Screening
Scientific Community
 
Become a Member | Sign in
Home>Resources>Application Notes>This Application Note
  Application Notes
Scientific News
Mass Spec Technology Drives Innovation Across the Biopharma Workflow
With greater resolving power, analytical speed, and accuracy, new mass spectrometry technology and techniques are infiltrating the biopharmaceuticals workflow.
One Step Closer to Precision Medicine for Chronic Lung Disease Sufferers
A study led by University of North Carolina at Chapel Hill, and National Jewish Health, has provided evidence of links between SNPs and known COPD blood protein biomarkers.
Identified Compound Stops Cells Making Ribosomes
From study in yeast, researchers have identifed a compound that interferes with the assembly of ribosomes.
CES Score May Predict Response to Cancer Treatment
Researchers identify new type of biomarker that helps predict prognosis and response to several types of cancer treatment.
Treating Sepsis with Marine Mitochondria
Mitochondrial alternative oxidase from a marine animal combats bacterial sepsis.
New Therapeutic Target for Crohn’s Disease
A promising new target for drugs that treat IBD has been identified along with a possible biomarker for IBD severity.
Analysing 10,000 Cells Simultaneously
New techniquethat traps 10,000 cells on a single chip has potential for cancer screening for individuals.
Researchers Find Fungus-Fighting Compound
A compound has been identifed that blocks growth of a fungus responsible for lung infections and allergic reactions.
Peer Reviewed Study Demonstrates Mass Spec Technique
The peer reviewed study demonstrates MS workflow, TMTCalibrator workflow, which dramatically enhances detection of key early stage Alzheimer’s biomarkers.
Enhancing Antibiotics to Defeat Resistant Bacteria
Scientists enhance ability of antibiotics to defeat resistant types of bacteria using molecules called PPMOs
Scroll Up
Scroll Down

Tag-liteTM: New HTRF® cellular platform for cell surface receptors’ study and screening
Bookmark and Share

Cisbio Bioassays

Summary

In a recent publication, Maurel et al* presented the combination of Cisbio’s HTRF and Covalys’ SNAP-and CLIP- Tag technologies to investigate cell-surface protein-protein interaction. In this study, an application for GPCR oligomerization was accurately documented and the advantages of this new approach presented.

Further Information

Related Content

Cisbio Bioassays and IGF Launch CNS Drug Discovery Research Program
Cisbio Bioassays, member of IBA Group and global provider of HTRF® (homogenous time resolved fluorescence) technology and services to facilitate drug discovery, has announced the launch of the GluSense research and development program in partnership with the Functional Genomics Institute of Montpellier, France.
Tuesday, November 30, 2010
Cisbio Bioassays Partners with Promega to Launch HaloTag® for Tag-lite®
Combination of HaloTag® and HTRF® technologies provides a new, flexible tool for cell surface receptor heterodimerization.
Thursday, September 23, 2010
Cisbio Bioassays Marks Second Milestone in China with new Demo Lab
Lab to support drug discovery customers in Asia by providing local training and services.
Thursday, July 22, 2010
Cisbio Bioassays Strengthens Presence in Asia
Global developer of drug screening tools and technologies now has local sales teams in China and South Korea.
Friday, November 06, 2009
Cisbio Bioassays Selects CyBio Robotic Workstation
The robotic workstation complements Cisbio’s expertise in creating and optimizing HTRF assays.
Wednesday, February 04, 2009
SELECTBIO

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
5,000+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!